Published in Int J Clin Exp Pathol on April 15, 2014
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell (1993) 10.83
Proliferation, cell cycle and apoptosis in cancer. Nature (2001) 9.57
Cellular senescence in cancer and aging. Cell (2007) 9.04
The essence of senescence. Genes Dev (2010) 8.21
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene (1994) 7.24
Four faces of cellular senescence. J Cell Biol (2011) 6.86
A matter of life and cell death. Science (1998) 5.33
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer (2006) 3.23
The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J (1996) 2.71
Cellular senescence and tumor suppressor gene p16. Int J Cancer (2011) 2.14
Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med (1996) 1.98
p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene (2011) 1.86
Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci U S A (2003) 1.63
Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J (2003) 1.59
Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene (1996) 1.51
Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol (1985) (2007) 1.42
Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood (2003) 1.35
Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol (2000) 1.35
Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene (2002) 1.32
BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Oncogene (2002) 1.17
Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation. J Biol Chem (2000) 1.12
Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors. J Invest Dermatol (2009) 1.10
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene (1999) 1.08
Bcl-2 expression delays hepatocyte cell cycle progression during liver regeneration. Oncogene (2002) 1.05
Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species. Oncogene (2009) 1.04
Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice. Cancer Res (1999) 1.01
Potential for EPR oximetry to guide treatment planning for tumors. Adv Exp Med Biol (1997) 0.89
Bcl-2 activates a programme of premature senescence in human carcinoma cells. Biochem J (2003) 0.89
Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol (2001) 0.85
Bcl-2 in cell cycle regulation. Cell Cycle (2004) 0.81
Bcl-2 promotes premature senescence induced by oncogenic Ras. Biochem Biophys Res Commun (2003) 0.79